CEVA Holding LCC, DB Schenker, and FedEx Corp are three key vendors highlighted in a new Technavio report
London, 13 July 2015 – Technavio has published a new report on the pharmaceutical logistics market in North America, which is expected to grow at a CAGR of more than 8% from 2015-2019.
Pharmaceutical logistics market segmentation including product and geography
Technavio’s report analyses the solutions and products offered by market vendors and presents a comprehensive breakdown in terms of market segmentation for different products, including generic drugs, branded drugs, and other drugs.
Additionally, analysts have segmented market projections by key geography, focusing on the US, Canada, and Mexico.
“It has been established that pharmaceutical logistics vendors in North America have found new opportunities in the biological drugs market, which can increase their revenue and market share. The growth of the biological drug market is due to increased use of biological drugs for the treatment of many chronic diseases,” says Faisal Ghaus, Vice President of Technavio.
Pharmaceutical logistics: Market scope and calculation of market size
In this report, Technavio covers the present scenario and growth prospects of the pharmaceutical logistics market in North America from 2015-2019. To calculate the market size, we have considered the revenue generated by third-party logistics service providers.
Industry analysis includes:
Key Vendors:
- CEVA Holding LCC
- DB Schenker
- FedEx Corp
- Kuehne + Nagel Inc.
- United Parcel Service of America Inc. (UPS)
Market Growth Drivers:
- High Demand for Logistics Outsourcing
- Increased Demand for Temperature-sensitive Pharmaceuticals
Market Challenges:
- Stringent Regulations
- Complex Supply Chain
Market Trends:
- Shift toward Biological Drugs
- Emergence of Big Data Analytics in SCM
View the pharmaceutical logistics market in North America report.
https://www.technavio.com/%3Cp%3E%3Cstrong%3E%3Ca%20href%3D%22http%3A//ww…
